Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Ipsen
  6. News
  7. Summary
    IPN   FR0010259150

IPSEN

(IPN)
  Report
Real-time Quote. Real-time Euronext Paris - 07/30 11:38:21 am
90.1 EUR   +1.78%
07/30IPSEN : Exceeding again our CSR-based targets
PU
07/29IPSEN : delivers strong H1 2021 results and upgrades full-year...
PU
07/29Ipsen S.A. Raises Sales Guidance for the Fiscal Year 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ipsen : US FDA Accepts Ipsen's Approval Request For Ultra-Rare Genetic Disorder Drug

05/31/2021 | 01:00am EDT


© MT Newswires 2021
All news about IPSEN
07/30IPSEN : Exceeding again our CSR-based targets
PU
07/29IPSEN : delivers strong H1 2021 results and upgrades full-year...
PU
07/29Ipsen S.A. Raises Sales Guidance for the Fiscal Year 2021
CI
07/28GLOBAL MARKETS LIVE : Apple, Alphabet, Facebook, Pfizer, McDonald's...
07/28IPSEN : strengthens its pre-clinical Oncology pipeline with an exclusive worldwi..
AQ
07/28IPSEN : BAKX Therapeutics to Develop Cancer Treatment
MT
07/27IPSEN : BAKX collaboration-27 July 2021
PU
07/27Ipsen and BAKX Therapeutics Inc. Signs Exclusive Worldwide-Collaboration Agre..
CI
07/16GLOBAL MARKETS LIVE : Intel, Moderna, Burberry, Pfizer, SoftwareOne, Swisscom...
07/16IPSEN : and IRLAB enter exclusive worldwide licensing agreement aimed to improve..
AQ
More news
Financials
Sales 2021 2 749 M 3 263 M 3 263 M
Net income 2021 580 M 688 M 688 M
Net cash 2021 22,6 M 26,9 M 26,9 M
P/E ratio 2021 12,8x
Yield 2021 1,16%
Capitalization 7 432 M 8 816 M 8 820 M
EV / Sales 2021 2,70x
EV / Sales 2022 2,57x
Nbr of Employees 5 700
Free-Float 41,9%
Chart IPSEN
Duration : Period :
Ipsen Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IPSEN
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 90,10 €
Average target price 93,31 €
Spread / Average Target 3,57%
EPS Revisions
Managers and Directors
David G. Loew Chief Executive Officer & Director
Aymeric Le Chatelier Chief Financial Officer & Executive Vice President
Marc M. P. de Garidel Non-Executive Chairman
Aidan Murphy Executive Vice President-Technical Operations
Howard Mayer Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IPSEN32.70%8 816
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343
ELI LILLY AND COMPANY44.22%221 348